SCHEMBL23927869

SCHEMBL23927869

CN(C)C(Cn1ccc2ccc(F)cc21)OC(=O)/C=C/C(=O)OC(Cn1ccc2ccc(F)cc21)N(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 6/20 0.51
HTR2A P28223 5/20 0.51
HTR7 P34969 1/20 0.37
NPY5R Q15761 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
AR P10275 2/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23927907 0.91 HTR2C (0.51) HTR2CHTR2AHTR7NPY5RSLC6A2
SCHEMBL23927819 0.87 HTR2C (0.50) HTR2CHTR2ANPY5RMTNR1AMTNR1B
SCHEMBL7678475 0.86 KMO (0.47) HTR2CHTR2AHTR7NPY5RSLC6A2
SCHEMBL23927824 0.83 KMT2A (0.44) HTR2CHTR2AHDAC1HDAC2HDAC10
SCHEMBL23927865 0.83 HTR2C (0.34) HTR2CHTR2AHPGD
SCHEMBL23927888 0.82 HTR7 (0.43) HTR7ARALDH1A1HPGDAPOBEC3G
SCHEMBL23927929 0.79 HTR2C (0.51) HTR2CHTR2AHTR7ARHDAC3
SCHEMBL23927937 0.79 HTR2C (0.53) HTR2CHTR2AMTNR1AMTNR1BHDAC3
SCHEMBL23927932 0.77 SLC6A4 (0.36) HTR2CHTR2ASLC6A2SLC6A4AR
SCHEMBL23927847 0.74 HTR2C (0.68) HTR2CHTR2AHTR7NPY5RP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-22 US disclosed
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA CORPORATION 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders TPH2, AANAT, HTR2C HTR2C 3/4885HTR2A 5/4885HTR7 32/4885
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS TPH2, AANAT, HTR2C HTR2C 3/4885HTR2A 5/4885HTR7 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.